Literature DB >> 21609260

Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.

Charles D Mackenzie, Timothy G Geary.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21609260     DOI: 10.1586/eri.11.30

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


× No keyword cloud information.
  40 in total

Review 1.  Oxfendazole: a promising agent for the treatment and control of helminth infections in humans.

Authors:  Armando E Gonzalez; Ellen E Codd; John Horton; Hector H Garcia; Robert H Gilman
Journal:  Expert Rev Anti Infect Ther       Date:  2018-12-10       Impact factor: 5.091

2.  Potential Role for Flubendazole in Limiting Filariasis Transmission: Observations of Microfilarial Sensitivity.

Authors:  Maeghan O'Neill; Jelil Abdel Njouendou; Michael Dzimianski; Erica Burkman; Patrick Chouna Ndongmo; Jonas A Kengne-Ouafo; Samuel Wanji; Andrew Moorhead; Charles D Mackenzie; Timothy G Geary
Journal:  Am J Trop Med Hyg       Date:  2018-01       Impact factor: 2.345

Review 3.  Present-day anthelmintics and perspectives on future new targets.

Authors:  Amira Taman; Manar Azab
Journal:  Parasitol Res       Date:  2014-06-04       Impact factor: 2.289

4.  Ocular onchocerciasis: current management and future prospects.

Authors:  Olufemi Emmanuel Babalola
Journal:  Clin Ophthalmol       Date:  2011-10-13

5.  The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data.

Authors:  Hugo C Turner; Martin Walker; Simon K Attah; Nicholas O Opoku; Kwablah Awadzi; Annette C Kuesel; María-Gloria Basáñez
Journal:  Parasit Vectors       Date:  2015-03-19       Impact factor: 3.876

6.  A histochemical study of the Nras/let-60 activity in filarial nematodes.

Authors:  James F Geary; Raquel Lovato; Samuel Wanji; Ron Guderian; Maeghan O'Neill; Sabine Specht; Nicole Madrill; Timothy G Geary; Charles D Mackenzie
Journal:  Parasit Vectors       Date:  2015-07-01       Impact factor: 3.876

7.  Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.

Authors:  Zhi-Jie Hou; Xi Luo; Wei Zhang; Fei Peng; Bai Cui; Si-Jin Wu; Fei-Meng Zheng; Jie Xu; Ling-Zhi Xu; Zi-Jie Long; Xue-Ting Wang; Guo-Hui Li; Xian-Yao Wan; Yong-Liang Yang; Quentin Liu
Journal:  Oncotarget       Date:  2015-03-20

8.  Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa.

Authors:  Young Eun Kim; Jan H F Remme; Peter Steinmann; Wilma A Stolk; Jean-Baptiste Roungou; Fabrizio Tediosi
Journal:  PLoS Negl Trop Dis       Date:  2015-04-10

9.  In vitro flubendazole-induced damage to vital tissues in adult females of the filarial nematode Brugia malayi.

Authors:  Maeghan O'Neill; James F Geary; Dalen W Agnew; Charles D Mackenzie; Timothy G Geary
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-07-07       Impact factor: 4.077

10.  Exploring the potential of flubendazole in filariasis control: evaluation of the systemic exposure for different pharmaceutical preparations.

Authors:  Laura Ceballos; Charles Mackenzie; Timothy Geary; Luis Alvarez; Carlos Lanusse
Journal:  PLoS Negl Trop Dis       Date:  2014-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.